Literature DB >> 23804100

The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons.

Amy Reeve1, Martin Meagher, Nichola Lax, Eve Simcox, Philippa Hepplewhite, Evelyn Jaros, Doug Turnbull.   

Abstract

Mitochondrial defects within substantia nigra (SN) neurons are implicated in the pathogenesis of Parkinson's disease. SN neurons show increased mitochondrial defects, mitochondrial DNA deletion levels, and susceptibility to such dysfunction, although the role of mitochondria in neuronal degeneration remains uncertain. In this study, we addressed this important question by exploring changes within the mitochondria of SN neurons from patients with primary mitochondrial diseases to determine whether mitochondrial dysfunction leads directly to neuronal cell loss. We counted the pigmented neurons and quantified mitochondrial respiratory activity, deficiencies in mitochondrial proteins, and the percentage of pathogenic mutations in single neurons. We found evidence of defects of both complex I and complex IV of the respiratory chain in all patients. We found that marked neuronal cell loss was only observed in a few patients with mitochondrial disease and that all these patients had mutations in polymerase gamma (POLG), which leads to the formation of multiple mitochondrial DNA deletions over time, similar to aging and Parkinson's disease. Interestingly, we detected α-synuclein pathology in two mitochondrial patients with POLG mutations. Our observations highlight the complex relationship between mitochondrial dysfunction and the susceptibility of SN neurons to degeneration and α-synuclein pathology. Our finding that the loss of SN neurons was only severe in patients with POLG mutations suggests that acquired mitochondrial defects may be less well tolerated by SN neurons than by inherited ones.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23804100      PMCID: PMC6618501          DOI: 10.1523/JNEUROSCI.3525-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  Early-onset familial parkinsonism due to POLG mutations.

Authors:  Guido Davidzon; Paul Greene; Michelangelo Mancuso; Kevin J Klos; J Eric Ahlskog; Michio Hirano; Salvatore DiMauro
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

2.  Accurate detection and quantitation of heteroplasmic mitochondrial point mutations by pyrosequencing.

Authors:  Helen E White; Victoria J Durston; Anneke Seller; Carl Fratter; John F Harvey; Nicholas C P Cross
Journal:  Genet Test       Date:  2005

3.  Mitochondrial complex I deficiency in Parkinson's disease.

Authors:  A H Schapira; J M Cooper; D Dexter; P Jenner; J B Clark; C D Marsden
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

Review 4.  Ubiquitin-proteasome system and mitochondria - reciprocity.

Authors:  Nurit Livnat-Levanon; Michael H Glickman
Journal:  Biochim Biophys Acta       Date:  2010-07-30

5.  Origin and functional consequences of the complex I defect in Parkinson's disease.

Authors:  R H Swerdlow; J K Parks; S W Miller; J B Tuttle; P A Trimmer; J P Sheehan; J P Bennett; R E Davis; W D Parker
Journal:  Ann Neurol       Date:  1996-10       Impact factor: 10.422

6.  Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism.

Authors:  Federica Invernizzi; Sara Varanese; Astrid Thomas; Franco Carrara; Marco Onofrj; Massimo Zeviani
Journal:  Neuromuscul Disord       Date:  2008-05-27       Impact factor: 4.296

7.  Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.

Authors:  Latha Devi; Vijayendran Raghavendran; Badanavalu M Prabhu; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

8.  Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene.

Authors:  A M Remes; R Hinttala; M Kärppä; H Soini; R Takalo; J Uusimaa; K Majamaa
Journal:  Parkinsonism Relat Disord       Date:  2008-03-05       Impact factor: 4.891

Review 9.  Expanding insights of mitochondrial dysfunction in Parkinson's disease.

Authors:  Patrick M Abou-Sleiman; Miratul M K Muqit; Nicholas W Wood
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

10.  Prevalence of mitochondrial DNA disease in adults.

Authors:  Andrew M Schaefer; Robert McFarland; Emma L Blakely; Langping He; Roger G Whittaker; Robert W Taylor; Patrick F Chinnery; Douglass M Turnbull
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

View more
  36 in total

1.  Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.

Authors:  Alicia M Pickrell; Chiu-Hui Huang; Scott R Kennedy; Alban Ordureau; Dionisia P Sideris; Jake G Hoekstra; J Wade Harper; Richard J Youle
Journal:  Neuron       Date:  2015-07-15       Impact factor: 17.173

Review 2.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

Review 3.  Mitochondria Initiate and Regulate Sarcopenia.

Authors:  Stephen E Alway; Junaith S Mohamed; Matthew J Myers
Journal:  Exerc Sport Sci Rev       Date:  2017-04       Impact factor: 6.230

Review 4.  The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms.

Authors:  Inhae Kang; Charleen T Chu; Brett A Kaufman
Journal:  FEBS Lett       Date:  2018-02-15       Impact factor: 4.124

5.  Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.

Authors:  Milena Pinto; Nadee Nissanka; Carlos T Moraes
Journal:  J Neurosci       Date:  2017-12-08       Impact factor: 6.167

6.  A Portrait of the Human Organelle Proteome In Space and Time during Cytomegalovirus Infection.

Authors:  Pierre M Jean Beltran; Rommel A Mathias; Ileana M Cristea
Journal:  Cell Syst       Date:  2016-09-15       Impact factor: 10.304

7.  Skeletal muscle mitochondrial DNA copy number and mitochondrial DNA deletion mutation frequency as predictors of physical performance in older men and women.

Authors:  Allen Herbst; Steven J Prior; Cathy C Lee; Judd M Aiken; Debbie McKenzie; Austin Hoang; Nianjun Liu; Xiwei Chen; Pengcheng Xun; David B Allison; Jonathan Wanagat
Journal:  Geroscience       Date:  2021-03-19       Impact factor: 7.713

Review 8.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

9.  The role of astrocytes in seizure generation: insights from a novel in vitro seizure model based on mitochondrial dysfunction.

Authors:  Felix Chan; Nichola Z Lax; Caroline Marie Voss; Blanca Irene Aldana; Shuna Whyte; Alistair Jenkins; Claire Nicholson; Sophie Nichols; Elizabeth Tilley; Zoe Powell; Helle S Waagepetersen; Ceri H Davies; Doug M Turnbull; Mark O Cunningham
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

Review 10.  Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.

Authors:  Jianhua Zhang; Matilda Lillian Culp; Jason G Craver; Victor Darley-Usmar
Journal:  J Neurochem       Date:  2018-02-14       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.